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4 Voltage-gated K + (Kv) channels are closed in the resting state, but are opened upon membrane depolarization and then inactivated for a wide variety of time courses. These channels are the primary modulators of neuronal excitability by altering the repolarization of action potentials and neuronal firing frequencies. In this respect, the inactivation mechanism involves the fine-tuning of Kv channels activity and plays an important role in the modulation of the temporal pattern of the activity of excitable neurons. The two electrophysiologically different types of Kv channels can be distinguished based on inactivation kinetics: delayed-rectifier and A-type K + channels.
Kv4.3, one of the major A-type currents, is rapidly activated and inactivated upon depolarization, and is expressed at high levels in brain, heart and smooth muscle (Ohya et al., 1997) . This channel is activated at a subthreshold membrane potential, therefore modulating the threshold for the spike generation of neurons (Yuan et al., 2002) . Thus, this channel may serve as an important target of certain drugs that are involved in the regulation of neuronal activity.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) is a neuroprotective agent, and has been shown to be effective in the treatment of convulsion in humans (Bryson et al., 1996; He et al., 2002) . The mechanisms of its therapeutic actions have been attributed to the interaction with the inactivated state of voltage-gated Na + and Ca 2+ channels (Benoit and Escande, 1991; Huang et al., 1997; Zona et al., 1998; Urbani and Belluzzi, 2000) , and its blocking properties make it a potential candidate used as an anticonvulsant drugs (Romettino et al., 1991; Stutzmann et al., 1991) . The actions of riluzole on these channels have been extensively investigated, but relatively little is known concerning its effects on Kv currents, especially on the A-type current. We and others have previously reported that riluzole interacts preferentially with the inactivated This article has not been copyedited and formatted. The final version may differ from this version. (Zona et al., 1998; Ahn et al., 2005) . However, riluzole also modulates several types of K + channels by alternate mechanisms (Duprat et al., 2000; Grunnet et al., 2001) . For example, riluzole induces the slowing of the inactivation by oxidation of a cysteine in the N-terminal inactivation domain of Kv1.4,
another A-type current (Xu et al., 2001) . Since Kv channels display a wide variety of time courses and kinetic properties in the inactivation process, an understanding of the modulation of channel inactivation by drugs has been a focus of intense interest. The purpose of the present study was to characterize the action of riluzole on the inactivation kinetics of Kv4.3, and compare its mechanisms of action with those for
Kv1.4.
This article has not been copyedited and formatted. The final version may differ from this version. supplemented with 10% fetal bovine serum, 0.1 mM hypoxanthine and 0.01 mM thymidine in a humidified 5% CO 2 incubator at 37°C. Kv4.3 constructs were stably transfected into CHO cells using the lipofectamine reagent (Invitrogen Corporation).
The transfected CHO cells in IMDM containing 1 mg/ml of geneticin (Invitrogen Corporation) were incubated for 48 h under a humidified 5% CO 2 incubator at 37°C.
The selected cells were cultured in 96 well plates by serial dilution with IMDM containing 0.5 mg/ml of geneticin and stable transfectants were selected by a prolonged culture period. The transfected cells were exchanged with fresh IMDM containing 0.3 mg/ml of geneticin and passed at 2 -3 day intervals using a brief trypsin-EDTA JPET #106724 8 using a two-pulse voltage protocol; currents were measured by 500 ms depolarizing pulses to +40 mV while 1 s preconditioning pulses were varied from -110 mV to +0 mV stepped by 5 mV at 10 s intervals in the absence and presence of the drug. The resulting steady-state inactivation data were fitted to the Boltzmann equation:
in which I max represents the current measured at the most hyperpolarized preconditioning pulse, I c a non-zero current which was not inactivated at the most depolarized preconditioning pulse, k the slope factor, V the test potential and V 1/2 the potential at which the conductance was half-maximal. We eliminated the non-zero residual current by subtracting it from the actual value.
The data are expressed as the mean ± S.E. One-way analysis of variance, followed by Dunnett's test, was used to evaluate the statistical significance of the observed differences. Statistical significance was considered at p < 0.05.
This article has not been copyedited and formatted. The final version may differ from this version. 14.8 ± 0.3 ms and a slow time constant (τ s ) of 107.6 ± 5.4 ms (n = 6). Riluzole had no effect on the fast inactivation (τ f ) of Kv4.3, but caused a significant decrease in the rate of slow inactivation with aτ s value of 113.0 ± 6.5 ms, 130.9 ± 10.5 ms and 145.5 ± 9.3 ms for 10, 30 and 100 µM (n = 6, p < 0.05), respectively ( 0.7% to 12.0 ± 0.8%, 14.6 ± 1.1% and 20.6 ± 0.7% (n = 6) for 10, 30 and 100 µM riluzole, respectively. The activation time constants were calculated by fitting a single exponential to the final 50% of activation (Snyders et al., 1993) . Under control conditions, the time constant of activation was 0.51 ± 0.06 ms (n = 6). In the presence of riluzole, the time constants of activation were 0.49 ± 0.05 ms and 0.46 ± 0.06 ms (n = 6) for 10 and 30 µM, respectively, indicating that the kinetics of activation were not significantly affected by riluzole. 3B) . However, the inhibition of Kv4.3 was larger at more depolarized potentials.
To quantify the voltage dependence of Kv4.3 inhibition, the relative currents before and after the application of riluzole were plotted as a function of test potential (Fig. 3C ). In the presence of riluzole, the inhibition increased steeply between -20 and + 20 mV. At a test potential of -20 mV, riluzole inhibited the Kv4.3 current by 5.7 ± 9.5% (n = 5).
This inhibition increased to 39.5 ± 4.7% at + 20 mV (n = 5, p < 0.05). Between + 30 and +60 mV where the maximal conductance is reached, however, the degree of inhibition was found to be uniform.
Shift of the Steady-State Inactivation Curves.
To assess the effect of riluzole on the voltage dependence of channel availability, steady-state inactivation curves were generated using standard double pulse protocols ( mV at 100 µM, n = 8, p < 0.05). However, no significant change in k for the curve in the presence of riluzole was found (4.8 ± 0.3 mV at 30 µM, 4.9 ± 0.2 mV at 100 µM, n = 8).
Whereas the apparent dissociation constant, K R , for the riluzole-induced inhibition of Kv4.3 in the closed state can be estimated from the reduction in the peak amplitude of the Kv4.3 current (Fig. 1) , the apparent dissociation constant, K i , for the riluzoleinduced inhibition in the inactivated state can be estimated from the concentrationdependent shift in the steady-state inactivation curve (Bean et al., 1983) . The theoretical value of K i was calculated to be 1.2 ± 0.5 µM (n = 8) (Fig. 4B) . Thus, the affinity of riluzole for the inactivated state of Kv4.3 is more than 90 times that for closed state.
Interaction with the Closed-Inactivated State. Because previous studies have shown that Kv4.3 channels are predominantly inactivated from the closed state (Beck and Covarrubias, 2001; Wang et al., 2005) , we examined the possible effect of riluzole on the kinetics of closed-state inactivation (Fig. 5A ). We used subthreshold depolarizing pulses (-60 mV), because the inactivation occurs predominantly from the close state at this holding potential. Under control conditions, a 12 s conditioning pulse to -60 mV inactivated 53.2 ± 4.3% (n = 8) of the Kv4.3 channels (Fig. 5B) . The time course for closed-state inactivation was fitted to a single exponential function with a time constant of 4.2 ± 0.5 s (n = 8). In the presence of 100 µM riluzole, the rate of close-stated inactivation was accelerated and inactivation was almost complete after a 1 s conditioning pulse. Closed-state inactivation was also fitted to a single exponential function with a time constant of 0.2 ± 0.03 s (n = 8, p < 0.05).
Use-dependent inhibition. The use-dependence of riluzole action was evaluated
This article has not been copyedited and formatted. The final version may differ from this version. with 10 consecutive pulses to +40 mV at 1 and 2 Hz. Under control conditions (Fig. 6A) , the Kv4.3 currents displayed a slight decline at 1 Hz (6.2 ± 2.4%, n = 6). This percentage increased to 30.2 ± 4.5 % (n = 6) at a frequency of 2 Hz. In the presence of 100 µM riluzole, the amplitude of the peak current declined more rapidly with successive pulses, reaching a steady-state level equivalent to 39.4 ± 4.4% of the control after 5 pulses at 1 Hz. The degree of frequency-dependent inhibition increased more markedly at 2 Hz. Thus, the potency of riluzole appears to be enhanced by increasing the frequency of the depolarizing stimulation.
Recovery from Inactivation of Kv4.3. The effects of riluzole on the kinetics of Kv4.3 recovery from steady-state inactivation are shown in Fig. 7A . Under control conditions, the recovery from the inactivation of Kv4.3 was complete after an interpulse interval of 1 s and was best fit to a single exponential function with a time constant of 258.4 ± 25.6 ms (n = 6) (Fig. 7B ). In the presence of 100 µM riluzole, however, the recovery process was best fit to a biexponential function with a fast time constant of 379.4 ± 51.7 ms and a slow time constant of 2001.6 ± 164.9 ms (n = 6). Both time constants differed significantly from the time constant under control conditions (n = 6, p < 0.05), indicating the slower recovery kinetics of Kv4.3 currents.
Reversibility of the Effects of Riluzole. Fig. 8A shows the results of a typical experiment in which a single pulse to +40 mV was repeated while 100 µM riluzole, separated by washout periods, was applied. Riluzole caused a decrease in the amplitude of Kv4.3 by about 50% within 1 min. The repeated application of riluzole caused the rapid inhibition of Kv4.3 but the peak amplitudes of the current were completely restored to the control values upon washout (Fig. 8B) Riluzole is a neuroprotective agent and its mechanism of action may involve, in part, the blocking of voltage-gated Na + channels (Taylor and Meldrum, 1995; Doble, 1996 Therefore, our observations confirm that the mechanism by which riluzole inhibits Kv4.3 is similar to those observed for several other delayed rectifier K + channels (Zona et al., 1998; Ahn et al., 2005) . However, other molecular mechanisms of action have been reported for riluzole. For example, riluzole slows the inactivation of Kv1.4 channels via the oxidation of a cysteine residue in the N-terminal inactivation ball (Xu et al., 2001) . Channel inactivation by membrane depolarization prevents the riluzoleinduced oxidation of a cysteine in the N-terminal domain of Kv1.4 channels. In the present study, however, the inhibitory effects of riluzole were more pronounced when Kv4.3 channels were inactivated. It is known that Kv1.4 and Kv4.3 are typical A-type currents which are rapidly activated and inactivated during depolarization. These types of channels are expressed primarily in pre-and postsynaptic membranes in central and peripheral neurons (Sheng et al., 1992) . Whereas Kv1.4 channels undergo an N-type inactivation (Lee et al., 1996) , Kv4.3 channels lack the ball moiety that causes an Ntype inactivation, do not follow typical N-type inactivation but include the putative concerted action of the cytoplasmic N-and C-terminal regions (Jerng and Covarrubias, 1997) . In addition, while the oxidation of cysteine residues in N-terminal domain affects the inactivation kinetics of Kv1.4 (Ruppersberg et al., 1991b; Stephens et al., 1996) , the modulation of inactivation by an oxidation/reduction mechanism has not been reported for Kv4.3 channels. More importantly, whereas the inactivation of Kv1.4 channels occurs only from the open state (Demo and Yellen, 1991) , Kv4.3 channels are inactivated from both the open and closed states and can enter the inactivated state directly from closed states without activation (Beck and Covarrubias, 2001; Wang et al., 2005) . Thus, the previous observations are extended and clarified by demonstrating that riluzole binds preferentially to the closed-inactivated states.
This article has not been copyedited and formatted. The final version may differ from this version. Another characteristic of the riluzole-induced inhibition of Kv4.3 was that the peak amplitude of the Kv4.3 currents was reduced and the subsequent inactivation of the current was slowed, resulting in the cross-over of the current traces obtained under control conditions and after the addition of riluzole. The instantaneous inhibition at the onset of a depolarizing pulse could be attributed to an interaction of riluzole with the closed state of the Kv4.3 channel. While the fast inactivation time course for Kv4.3 was not altered by riluzole, the slow time course was slowed substantially. One possible explanation is that the slowing of inactivation could also due to delayed activation and inactivation. These effects have been described in A-type current I to with a similar mode (Campbell et al., 1993) . In ferret ventricular myocytes, 4-AP not only reduced the peak amplitude of I to but also slowed the apparent rate of both the activation and inactivation processes, resulting in the cross-over of the current. These results suggest that 4-AP inhibits I to through a closed state blocking mechanism. Because the activation kinetics
were not affected by riluzole in the present study, the rate at which channels are delivered to the open state from the closed state was slowed due to delayed drug dissociation. Thus, riluzole must unbind from the closed channel during the late phase of the depolarizing pulse, and the channel enters into the open state after the dissociation of the drug and inactivates at a normal rate, which led to a cross-over phenomenon. Similar results have been reported for 4-AP on Kv4.2 (Kirsch et al., 1986) and EGCG on Kv1.5 (Choi et al., 2001) : the closed state inhibition can be relieved during membrane depolarization due to the unbinding of the drug from the channel at not from the closed-inactivated state without deactivation at the hyperpolarized membrane potential, as is the case for Na + channels (Kuo and Bean, 1994) . Thus, these results suggest that the mechanism of slowing of the inactivation kinetics by riluzole involves a reversal of closed channel inhibition during membrane depolarization.
Based on the shift in steady-state inactivation curves, we estimated the K i for binding to inactivated channels to be 1.2 µM. Thus, the affinity of riluzole for the inactivated state appears to be more than 90 times higher than that for the closed state.
At the recommended daily dose, the average plasma levels of riluzole are in the range between 1-2 µM (Le Liboux et al., 1997) . The K i of 1.2 µM for the inactivated state of Kv4.3 is comparable to the previously reported value for blocking the inactivated Na + channels in rat cortical neurons (Urbani and Belluzzi, 2000) and this concentration can potential and neuronal firing pattern. Kv4.3 is primarily expressed in the soma and dendrites of neurons (Serodio and Rudy, 1998) , and is activated at subthreshold membrane potentials, thus limiting the back-propagation of the action potential into dendrites and regulating membrane excitability in the hippocampus (Yuan et al., 2002) .
For example, the inhibition of dendritic A-type channels can modulate the action potential threshold and increase dendritic excitability and the back-propagation of the action potential in the dendrites of hippocampal pyramidal neurons (Hoffman and Johnston, 1998) . Therefore, effect of riluzole on Kv4.3 channels observed in the present study could affect the neuronal excitability, which would be adverse to the neuroprotective action of the drug. However, correlating experimental data with clinical implications must proceed with great caution, because riluzole is a non-selective ion channel inhibitor and affects several other ionic currents that are responsible for the configuration of the action potentials. The overall effects of riluzole on neuronal excitability are determined by the sum of the complex interactions of the drug with multiple ion channels through different neuronal membranes. In fact, riluzole decreases current-evoked firing discharge in striatal spiny (Centonze et al., 1998) and cortical neurons (Urbani and Belluzzi, 2000) , consistent with the use of this drug as a neuroprotective agent. It should also be noted that the pore-forming α -subunit of the Kv4.3 channel protein by itself can form a voltage-gated K + channel in heterologous expression systems but Kv4.3 co-assembles with a large variety of auxiliary subunits, including K + channel interacting proteins (KChIPs) in native cells. The interaction of these proteins alters the biophysical properties and drug sensitivity of Kv4.3 channels (Beck et al., 2002; Bett et al., 2006) . Thus, the Kv4. value of 115.6 ± 7.6 µM and a Hill coefficient of 2.4 ± 0.3 for riluzole (n = 6). Data are expressed as means ± S.E. currents were recorded at +40 mV using a double-pulse protocol with a conditioning pulse to -60 mV of variable duration. The initial control pulse and conditioning pulse were applied from a membrane potential of -100 mV. (B) The current amplitudes evoked by the second pulse, relative to the amplitude obtained by the initial control pulse, were plotted against the duration of the conditioning pulse. The data were fit well to a single-exponential function (n = 8). Data are expressed as means ± S.E. 
